ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Posted by on Jan 19th, 2025

StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the stock.

ObsEva Price Performance

The firm has a market capitalization of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14.

About ObsEva

(Get Free Report)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Further Reading

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.